Join to View Full Profile
601 North Caroline StreetBaltimore, MD 21287
Phone+1 410-955-9441
Fax+1 410-955-6402
Dr. Maragakis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1998 - 1999- Johns Hopkins UniversityResidency, Neurology, 1995 - 1998
University of Utah HealthInternship, Internal Medicine, 1994 - 1995
University of Utah School of MedicineClass of 1994
Certifications & Licensure
MD State Medical License 1998 - 2025
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2012 Jan 01
- Clinical Trial of Ezogabine (Retigabine) in ALS Subjects Start of enrollment: 2015 Jun 01
- Evaluation of MN-166 (ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with ALS Start of enrollment: 2020 May 28
- Join now to see all
Publications & Presentations
PubMed
- Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial.Jeremy M Shefner, Merit E Cudkowicz, Angela Genge, Orla Hardiman, Ammar Al-Chalabi
JAMA Neurology. 2025-03-24 - ALSUntangled #78: Zinc.Benjamin Helmold, George Nathaniel, Paul Barkhaus, Tulio Bertorini, Mark Bromberg
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-03-14 - Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial., Jeremy M Shefner, Björn Oskarsson, Eric A Macklin, Lori B Chibnik
JAMA. 2025-02-17
Journal Articles
- Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral SclerosisBrian J Wainger, Nicholas J Maragakis, Richard Bedlack, Namita A Goyal, Seward B Rutkove, Michael H Rivner, Stephen A Goutman, Shafeeq S Ladha, Elizabeth A Mauricio, R..., JAMA Neurology
- Motor Neuron-Derived microRNAs Cause Astrocyte Dysfunction in Amyotrophic Lateral SclerosisJeffrey D Rothstein, Nicholas J Maragakis, Timothy M Miller, Brain
Other
- Motoneuron Disease: ClinicalNicholas Maragakis, MD, Springer
https://www.doximity.com/articles/11995bea-a048-4cec-bc0f-7564c791758a
UpToDate, Wolters Kluwer Health - 2012-10-23
Press Mentions
Clinical Research Week: Your Path to Advancing ALS ResearchJanuary 21st, 2025- What Is Pseudobulbar Affect? Symptoms, Causes, Diagnosis, Treatment, and PreventionFebruary 4th, 2023
- Johns Hopkins Researchers Identify Potential Window for Treating ALSApril 8th, 2022
- Join now to see all
Grant Support
- Modulating an Astrocyte Hemichannel to Delay Spatial and Temporal Progression in ALS.JOHNS HOPKINS UNIVERSITY2020–2025
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/nicholas-maragakis
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
